학술논문

A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
Document Type
Article
Source
In: Cephalalgia. (Cephalalgia, April 2024, 44(4))
Subject
Language
English
ISSN
14682982
03331024